Press and Media
How Technology, Early Diagnoses Can Help Turn The Tide On Prostate Cancer Prognosis
Dr. Ali Tinazli’s post at the Forbes magazine about “How Technology, Early Diagnoses Can Help Turn The Tide On Prostate Cancer Prognosis”
Lifespin Announces Expansion of Laboratory Testing Capability
New investments in testing infrastructure will enable Lifespin to analyze up to 300,000 patient samples …
Lifespin Launches Commercial Access to its Metabolic Profiler Software and Database for Pharma and Biobank Services
New commercial services will provide powerful insights to aid in research, development, and manufacturing by …
Why Knowledge Is Power In The Treatment Of Obesity
Dr. Ali Tinazli’s post at the Forbes magazine about “Why Knowledge Is Power In The Treatment Of Obesity”
How Lifespin revolutionizes the diagnosis of diseases with metabolic information and artificial intelligence
An interview by 5-HT Digital Hub Chemistry & Health with Dr. Ali Tinazli
Lifespin Significantly Expands its Proprietary Database of Human Health Profiles in Oncology Under Newly Established Cooperative Scientific Agreement with the Medical University of Graz
lifespin’s agreement with Medical University Graz which garants access to more than 25,000 longitudinal blood samples
The Bio Revolution Brings Innovation For Precision Diagnostics
Dr. Ali Tinazli’s first post at the Forbes magazine about “The Bio Revolution Brings Innovation For Precision Diagnostics”
Metabolomics, an emerging clinical modality, enabling precision, personalized medicine
Metabolomics, an emerging clinical modality, enabling precision, personalized medicine
Metabolomics: The Next Step in Precision Medicine
Metabolomics can measure the actual physiological state of an individual, providing new health insights
Lifespin Establishes U.S. Corporate Entity in Anticipation of Market Expansion
BOSTON (MA), April 12th, 2022 — Lifespin GmbH, a deep data company that is mapping …
Article about lifespin GmbH in the regional press (Donaukurier)
Das Regensburger Unternehmen Lifespin digitalisiert Stoffwechselproben und wagt heuer den Sprung in die USA – Auch die Harvard University ist bei der Entwicklung beteiligt
lifespin GmbH secures €2.5M Bridge Financing
Lifespin GmbH Secures €2.5M Bridge Financing to Further Build its AI-Enabled
Metabolomics-Based Differential Diagnosis Panel for Neurological Diseases